Yahoo Web Search

  1. Ads
    related to Bristol-Myers Squibb Company
  1. Prior to today's trading, shares of the biopharmaceutical company had lost 8.07% over the past month. This has lagged the Medical sector's gain of 2.13% and the S&P 500's gain of 5.68% ...

  2. Prior to today's trading, shares of the biopharmaceutical company had lost 13.2% over the past month. This has lagged the Medical sector's loss of 0.07% and the S&P 500's gain of 2.39% ...

  3. Holding the marketwide bullish effort back was Boston Beer Company (NYSE:SAM). Campbell Soup Company has been a miserable performer since the middle of 2016, losing nearly half ...

  4. Bristol-Myers Squibb Co's shareholders voted to approve the drugmaker's $74 billion acquisition of biotech Celgene Corp on Friday despite a campaign by activist hedge fund ...

  5. It is worth considering Bristol-Myers Squibb (BMY), which belongs to the Zacks Large Cap Pharmaceuticals industry. When looking at the last two reports, this biopharmaceutical ...

  6. Bristol-Myers' Shareholders Vote for Celgene Acquisition

    Zacks via Yahoo FinanceApr 15 17:53 PM

    Bristol-Myers Squibb Company BMY announced that its shareholders have given a green signal for the impending acquisition of Celgene Corp. CELG. In January, Bristol ...

  7. Will Bristol-Myers (BMY) Disappoint This Earnings Season?

    Zacks via Yahoo FinanceApr 22 12:30 PM

    Bristol-Myers Squibb Company BMY is scheduled to report first-quarter 2019 results on Apr 25, before market opens. Bristol-Myers has delivered average ...

  8. BMY Stock Looks Really Appetizing as the Celgene Merger Approaches

    InvestorPlace via Yahoo FinanceApr 11 12:15 PM

    The mega-merger between Bristol-Myers Squibb (NYSE:BMY) and Celgene (NASDAQ:CELG) appears to be drawing closer to fruition. Is it time to buy BMY stock ahead of the merger ...

  9. Wall Street expects a year-over-year increase in earnings on higher revenues when Bristol-Myers Squibb (BMY) reports results for the quarter ended March 2019. While this ...

  10. Is Celgene Stock Still Worth Holding Onto in the Long Run?

    InvestorPlace via Yahoo FinanceApr 03 18:18 PM

    Celgene Corporation (NASDAQ:CELG), which is going through the process of getting bought out by Bristol-Myers Squibb (NYSE:BMY), rose 7% on Friday, March 29. “Under the terms ...

  1. Ads
    related to Bristol-Myers Squibb Company